Axeon Research

Axeon Research is a clinical research organization and biotechnology company based in Port Orange, Florida, that specializes in the execution of Phase I-IV clinical trials across diverse therapeutic areas. The company has expanded into drug development through a strategic international joint venture with Ever Supreme Bio Technology and Minerva Scientifics, focused on the clinical advancement of allogeneic umbilical cord mesenchymal stem cell (UMSC01) therapies. This collaboration targets high-unmet-need indications, including myocardial infarction, stroke, multiple sclerosis, and COVID-19, for global markets including the US, Europe, and Japan. Axeon Research leverages its extensive clinical site infrastructure and regulatory expertise to accelerate the development and commercialization of regenerative medicine and cell-based therapeutics.